procainamide has been researched along with Brugada ECG Pattern in 34 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This case report highlights a patient who developed drug-induced Brugada type I pattern after a procainamide infusion for the treatment of new-onset atrial fibrillation (AF) or flutter and discusses the implications for this incidental but potentially lethal finding." | 8.31 | Procainamide-Provoked Brugada Pattern in a Patient Presenting with New-Onset Atrial Fibrillation or Flutter: When Does it Matter? ( Balasubramanian, S; Freedman, Z; Katz, A, 2023) |
| "This study aimed to investigate the predictive value of T-peak to T-end interval and corrected T-peak to T-end interval for predicting the positive response of the ajmaline challenge test in suspected Brugada syndrome patients." | 8.12 | T-Peak to T-End Interval for Prediction of Positive Response to Ajmaline Challenge Test in Suspected Brugada Syndrome Patients. ( Chokesuwattanaskul, R; Leelapatana, P; Prechawat, S; Rungpradubvong, V; Thapanasuta, M, 2022) |
| " This case report highlights a patient who developed drug-induced Brugada type I pattern after a procainamide infusion for the treatment of new-onset atrial fibrillation (AF) or flutter and discusses the implications for this incidental but potentially lethal finding." | 4.31 | Procainamide-Provoked Brugada Pattern in a Patient Presenting with New-Onset Atrial Fibrillation or Flutter: When Does it Matter? ( Balasubramanian, S; Freedman, Z; Katz, A, 2023) |
| " When DL was applied to consecutive 10-second, clean ECGs from 24-hour 12-lead Holters, spontaneous Brugada type 1 was detected in 48% of patients with procainamide-induced Brugada syndrome and in 33% with suspected Brugada syndrome." | 4.12 | Use of Wearable Technology and Deep Learning to Improve the Diagnosis of Brugada Syndrome. ( Bokhari, M; Chakraborty, P; Chauhan, VS; Gollob, M; Jones, G; Liao, S; Spears, D; Suszko, A; Wang, B; Zhang, Z, 2022) |
| "This study aimed to investigate the predictive value of T-peak to T-end interval and corrected T-peak to T-end interval for predicting the positive response of the ajmaline challenge test in suspected Brugada syndrome patients." | 4.12 | T-Peak to T-End Interval for Prediction of Positive Response to Ajmaline Challenge Test in Suspected Brugada Syndrome Patients. ( Chokesuwattanaskul, R; Leelapatana, P; Prechawat, S; Rungpradubvong, V; Thapanasuta, M, 2022) |
| "Irrespective of the baseline ECG, procainamide testing provoked a Brugada pattern in a significant proportion of subjects with UCA or a FHSD, thereby facilitating a diagnosis of Brugada syndrome, and is recommended in the workup of UCA." | 3.80 | Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). ( Angaran, P; Birnie, DH; Chakrabarti, S; Champagne, J; Chauhan, VS; Gardner, M; Gerull, B; Gollob, MH; Gow, RM; Gula, LJ; Healey, JS; Klein, GJ; Krahn, AD; Leong-Sit, P; Sanatani, S; Simpson, CS; Skanes, AC; Somani, R; Talajic, M; Yee, R, 2014) |
| "Procainamide is known to prolong PR, QRS, and QTc intervals in adults and is utilized to unmask the distinct electrocardiographic signatures, including right bundle branch block pattern and right precordial ST segment elevation seen with Brugada syndrome." | 3.80 | Universal ECG changes in pediatric patients undergoing procainamide challenge. ( Berul, CI; Greene, EA; Jordan, CP; Moak, JP, 2014) |
| "Procainamide is a sodium channel blocker used to diagnose BrS." | 1.62 | The clinical utility of procainamide-induced late potentials on the signal averaged ECG. ( Alqarawi, W; Krahn, AD; Laksman, Z; Larsen, JM; Leach, E; Pearman, CM; Walia, J, 2021) |
| "The Brugada syndrome is a heterogeneous genetic disease that predisposes to life-threatening ventricular tachyarrhythmias and sudden cardiac death (SCD)." | 1.39 | Positive Brugada challenge test in V1 R-V3 R as a predictor of malignant prognosis in Brugada patients. ( Aslani, A; Emkanjoo, Z; Hashemi, A; Saber, S; Shahrzad, S; Taban, S, 2013) |
| "The ECG features of Brugada syndrome are dynamic and frequently concealed." | 1.36 | Sensitivity and specificity of sodium channel blocking test in the diagnosis of Brugada syndrome. ( Efremidis, M; Gavrielatos, G; Kardaras, F; Letsas, KP; Pappas, LK; Sideris, A, 2010) |
| " Log dose-response curves were plotted for quinidine, papaverine, procaine, dibenamine and procaine amide." | 1.24 | A comparison of tests for antifibrillatory action. ( SZEKERES, L; WILLIAMS, EM, 1961) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (55.88) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (11.76) | 29.6817 |
| 2010's | 7 (20.59) | 24.3611 |
| 2020's | 4 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Pearman, CM | 1 |
| Walia, J | 1 |
| Alqarawi, W | 1 |
| Larsen, JM | 1 |
| Leach, E | 1 |
| Krahn, AD | 3 |
| Laksman, Z | 1 |
| Liao, S | 1 |
| Bokhari, M | 1 |
| Chakraborty, P | 1 |
| Suszko, A | 1 |
| Jones, G | 1 |
| Spears, D | 1 |
| Gollob, M | 1 |
| Zhang, Z | 1 |
| Wang, B | 1 |
| Chauhan, VS | 3 |
| Thapanasuta, M | 1 |
| Chokesuwattanaskul, R | 1 |
| Leelapatana, P | 1 |
| Rungpradubvong, V | 1 |
| Prechawat, S | 1 |
| Katz, A | 1 |
| Balasubramanian, S | 1 |
| Freedman, Z | 1 |
| Cheung, CC | 1 |
| Mellor, G | 1 |
| Deyell, MW | 1 |
| Ensam, B | 1 |
| Batchvarov, V | 1 |
| Papadakis, M | 1 |
| Roberts, JD | 1 |
| Leather, R | 1 |
| Sanatani, S | 2 |
| Healey, JS | 2 |
| Birnie, DH | 2 |
| Champagne, J | 2 |
| Angaran, P | 2 |
| Klein, GJ | 2 |
| Yee, R | 2 |
| Simpson, CS | 2 |
| Talajic, M | 2 |
| Gardner, M | 2 |
| Yeung-Lai-Wah, JA | 1 |
| Chakrabarti, S | 2 |
| Laksman, ZW | 1 |
| Sharma, S | 1 |
| Behr, ER | 2 |
| Sun, AY | 1 |
| Hashemi, A | 1 |
| Shahrzad, S | 2 |
| Saber, S | 1 |
| Taban, S | 1 |
| Aslani, A | 1 |
| Emkanjoo, Z | 1 |
| Somani, R | 1 |
| Gow, RM | 1 |
| Gerull, B | 1 |
| Skanes, AC | 1 |
| Gula, LJ | 1 |
| Leong-Sit, P | 1 |
| Gollob, MH | 1 |
| Jordan, CP | 1 |
| Berul, CI | 1 |
| Moak, JP | 1 |
| Greene, EA | 1 |
| Camm, AJ | 1 |
| Gavrielatos, G | 1 |
| Letsas, KP | 1 |
| Pappas, LK | 1 |
| Efremidis, M | 1 |
| Sideris, A | 1 |
| Kardaras, F | 1 |
| Reiffel, JA | 1 |
| ZURN, L | 1 |
| KLOPPE, W | 1 |
| CONTI, A | 1 |
| DANESE, C | 1 |
| HAEGER, K | 2 |
| JOHANSSON, B | 2 |
| SJOSTROM, B | 2 |
| VOIT, K | 1 |
| SECKFORT, H | 1 |
| EICHLER, O | 1 |
| CATINAT, J | 1 |
| CASASSUS, P | 1 |
| LIPOVETSKII, BM | 1 |
| ROZIN, MZ | 1 |
| WILLIAMS, EM | 1 |
| SZEKERES, L | 1 |
| KEMPEN, RR | 1 |
| VAN HORN, G | 1 |
| TERNOVA, TI | 1 |
| BRANCADORO, G | 1 |
| URSINI, M | 1 |
| WINBURY, MM | 1 |
| HEMMER, ML | 1 |
| SANABRIA, A | 1 |
| CARBONELL, LM | 1 |
| SOTO, R | 1 |
| MORRIS, LE | 1 |
| HAID, B | 1 |
| McCORD, MC | 1 |
| TAGUCHI, JT | 1 |
| BERRY, K | 1 |
| GARLETT, EL | 1 |
| BELLET, S | 1 |
| GEFTER, WI | 1 |
| MARTELLI, A | 1 |
| COMISIONERU, N | 1 |
| Joshi, S | 1 |
| Raiszadeh, F | 1 |
| Pierce, W | 1 |
| Steinberg, JS | 1 |
| Otten, RF | 1 |
| Dusa, AC | 1 |
| Das, MK | 1 |
| Junttila, MJ | 1 |
| Gonzalez, M | 1 |
| Lizotte, E | 1 |
| Benito, B | 1 |
| Vernooy, K | 1 |
| Sarkozy, A | 1 |
| Huikuri, HV | 1 |
| Brugada, P | 1 |
| Brugada, J | 1 |
| Brugada, R | 1 |
1 review available for procainamide and Brugada ECG Pattern
| Article | Year |
|---|---|
Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias.
Topics: Adult; Age of Onset; Anesthetics; Antidepressive Agents, Tricyclic; Brugada Syndrome; Cocaine; Death | 2008 |
33 other studies available for procainamide and Brugada ECG Pattern
| Article | Year |
|---|---|
The clinical utility of procainamide-induced late potentials on the signal averaged ECG.
Topics: Adult; Brugada Syndrome; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Volta | 2021 |
Use of Wearable Technology and Deep Learning to Improve the Diagnosis of Brugada Syndrome.
Topics: Brugada Syndrome; Deep Learning; Electrocardiography; Humans; Procainamide; Wearable Electronic Devi | 2022 |
T-Peak to T-End Interval for Prediction of Positive Response to Ajmaline Challenge Test in Suspected Brugada Syndrome Patients.
Topics: Ajmaline; Brugada Syndrome; Flecainide; Humans; Procainamide; Sodium Channel Blockers | 2022 |
Procainamide-Provoked Brugada Pattern in a Patient Presenting with New-Onset Atrial Fibrillation or Flutter: When Does it Matter?
Topics: Atrial Fibrillation; Brugada Syndrome; China; Death, Sudden, Cardiac; Electrocardiography; Humans; M | 2023 |
Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome.
Topics: Adult; Ajmaline; Brugada Syndrome; Cohort Studies; Electrocardiography; Female; Humans; Male; Middle | 2019 |
Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.
Topics: Ajmaline; Anti-Arrhythmia Agents; Brugada Syndrome; Humans; NAV1.5 Voltage-Gated Sodium Channel; Pro | 2019 |
Positive Brugada challenge test in V1 R-V3 R as a predictor of malignant prognosis in Brugada patients.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Female; Flecainide | 2013 |
Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER).
Topics: Adolescent; Adult; Aged; Brugada Syndrome; Female; Heart Arrest; Humans; Male; Middle Aged; Procaina | 2014 |
Universal ECG changes in pediatric patients undergoing procainamide challenge.
Topics: Brugada Syndrome; Child; Diagnosis, Differential; Electrocardiography; Female; Humans; Male; Procain | 2014 |
Letter by Behr and Camm regarding article, "Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias".
Topics: Adult; Age of Onset; Anesthetics; Antidepressive Agents, Tricyclic; Brugada Syndrome; Cocaine; Death | 2008 |
Sensitivity and specificity of sodium channel blocking test in the diagnosis of Brugada syndrome.
Topics: Aged; Anti-Arrhythmia Agents; Brugada Syndrome; Echocardiography; Electrocardiography; Humans; Male; | 2010 |
Does a Brugada pattern ECG precipitated by excessive-dose flecainide provide a diagnosis of a Brugada syndrome patient and/or contraindicate its use? A case study.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Brugada Syndrome; Catheter Ablation; Contraindications; | 2011 |
[Autonomic block with novocaine and novocaine amide; prevention and therapy of cardiac arrhythmia during narcosis].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; | 1953 |
[Auricular flutter and fibrillation and their response to novocamide].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction Syst | 1954 |
[Procaine amide therapy of postoperative cardiac arrhythmia].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Electrocardiography; Hear | 1954 |
Electrocardiographic studies on fibrillating and nonfibrillating hypothermic dogs with or without previous treatment with acetylcholine or procaine amide.
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; D | 1957 |
Electrocardiographic studies on fibrillating and nonfibrillating hypothermic dogs with or without previous treatment with acetylcholine or procaine amide.
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; D | 1957 |
Electrocardiographic studies on fibrillating and nonfibrillating hypothermic dogs with or without previous treatment with acetylcholine or procaine amide.
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; D | 1957 |
Electrocardiographic studies on fibrillating and nonfibrillating hypothermic dogs with or without previous treatment with acetylcholine or procaine amide.
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; D | 1957 |
[A new combined quinidine preparation for therapy of cardiac arrhythmia].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; | 1957 |
[Clinical use of procaine amide in the treatment of cardiac arrhythmia].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; | 1957 |
[Therapy of cardiac rhythm disorders by procaine amide; preliminary communication].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Communication; Heart Cond | 1959 |
[Use of novocaine amide in the permanent form of cardiac fibrillation].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Hear | 1963 |
A comparison of tests for antifibrillatory action.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Complexes, Prematur | 1961 |
Effects of antiarrhythmic drugs on external fibrillation and defibrillation thresholds.
Topics: Anti-Allergic Agents; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduc | 1963 |
[APROPOS OF THE USE OF NOVOCAINAMIDE IN CARDIAC ARRHYTHMIA IN CHILDREN].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Complexes, Premature; Cardiac C | 1964 |
[Prevention of various cardiac rhythm disorders experimentally induced].
Topics: Arrhythmias, Cardiac; Autonomic Agents; Brugada Syndrome; Cardiac Conduction System Disease; Heart C | 1954 |
Action of quinidine, procaine amide and other compounds on experimental atrial and ventricular arrhythmias in the dog.
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Dogs; Heart Cond | 1955 |
Action of procainamide, quinidine and chloroquine upon the conduction system of the dog's heart (histochemical study).
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Chloroquine; Dog | 1959 |
Effects of procaine amide on cardiac irregularities during cyclopropane anesthesia.
Topics: Anesthesia; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cyclopropanes | 1951 |
A study of the effect of procaine amide hydrochloride in supraventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Hear | 1951 |
Use of pronestyl in the treatment of ectopic rhythms; treatment of 98 episodes in 78 patients.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; | 1951 |
[Effect of procaine amide monohydrochloride in cardiac arrhythmia of extrasystolic origin].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; | 1951 |
[Procaine amide therapy of extra-systolic ventricular arrhythmia].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; | 1952 |
Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Impl | 2007 |
Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy.
Topics: Anti-Arrhythmia Agents; Atropine; Brugada Syndrome; Cardiotonic Agents; Cholinesterase Inhibitors; C | 2007 |